New CDC Vaccine Guidelines Mirror Florida’s Controversial COVID Stance
The U.S. Centers for Disease Control and Prevention (CDC) has officially removed COVID-19 mRNA vaccines from its recommended immunization schedule for healthy children and pregnant women, following an announcement by U.S. Health and Human Services Secretary Robert F. Kennedy Jr.
The change marks a significant shift in national vaccination guidance, coming after years of evolving research and public debate over the necessity and safety of mRNA-based COVID-19 vaccines in these groups.
Florida has been at the forefront of this conversation. In 2022, the state was the first to issue guidance advising against COVID-19 mRNA vaccination for healthy children. In early 2024, Florida expanded that guidance to recommend against the use of the vaccines across all age groups.
State Surgeon General Dr. Joseph Ladapo responded to the CDC update, stating, “Florida has continually demanded honest science and accountability in our public health decisions. [May 28’s] federal action, thanks to the tireless efforts of Secretary Kennedy, is an important advancement for parents, physicians, and children across the country. Ultimately, scientific evidence dictates that the use of these products should end for all populations.”
Florida officials have cited concerns about potential adverse events—such as myocarditis—and limited long-term data as factors in their guidance. The state has also called for further investigation into how pharmaceutical interests influence federal health recommendations.
The CDC’s decision does not impact vaccine availability, and individuals can still choose to receive COVID-19 vaccines. However, the update signals a shift in how the vaccines are officially recommended for routine use.
Federal and state health authorities continue to emphasize the importance of evaluating individual risk factors and discussing medical decisions with a healthcare provider.
The full press release can be found on the Florida Department of Health’s website here.
